4.6 Article

Uncovering tau in wasteosomes (corpora amylacea) of Alzheimer's disease patients

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP-43 inclusions and ageing-related tau astrogliopathy in a family with a GBE1 mutation

Maiko T. Uemura et al.

Summary: This study reports on a family with siblings who have prominent frontotemporal lobar degeneration and underlying copathologies of APBD, FTLD-TDP, and ARTAG. The mutation in their gene may lead to a common pathological mechanism for these diseases.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration

Niklas Mattsson-Carlgren et al.

Summary: This study investigates the correlation between CSF biomarkers and neuropathologic changes in Alzheimer's disease and frontotemporal lobar degeneration. The results show that CSF biomarkers can aid in the identification and diagnosis of these neurodegenerative diseases.

NEUROLOGY (2022)

Article Medicine, General & Internal

Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease

Nicholas J. Ashton et al.

Summary: CSF p-tau epitopes increase early in the development of AD pathology and are a primary candidate for detecting incipient Aβ pathology.

EBIOMEDICINE (2022)

Article Multidisciplinary Sciences

Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency

Marta Riba et al.

Summary: The glymphatic system in the brain plays a crucial role in the drainage and cleaning function, similar to the lymphatic system in other organs and tissues. This article introduces the concept of glymphatic insufficiency and proposes that corpora amylacea or wasteosomes are manifestations of chronic glymphatic insufficiency. Furthermore, it suggests that wasteosomes can provide valuable information about the impact of different variables on the glymphatic system and the occurrence of diseases related to glymphatic insufficiency.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Neurosciences

Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology

Giavanna Paterno et al.

Summary: Tau is a neuronal protein that can stabilize microtubules in the central nervous system. It is extensively studied in the context of neurodegenerative diseases, such as Alzheimer's disease, where it forms pathological inclusions. Contrary to previous belief, recent research shows that Tau is more abundant in cortical gray matter enriched in neuronal soma and dendrites, rather than in axons.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Neurosciences

Corpora amylacea are associated with tau burden and cognitive status in Alzheimer's disease

Connor M. Wander et al.

Summary: Corpora amylacea (CA) and their murine analogs, periodic acid Schiff (PAS) granules, are carbohydrate-rich structures that serve as waste repositories for aggregated proteins, damaged cellular organelles, and other cellular debris. This study connects CA with the progression of Alzheimer's disease (AD) and suggests that CA may act as a compensatory factor that becomes depleted with advancing tau burden.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Wasteosomes (corpora amylacea) of human brain can be phagocytosed and digested by macrophages

Marta Riba et al.

Summary: Wasteosomes, also known as corpora amylacea, are granular structures in the brain that accumulate during aging and neurodegenerative conditions. Macrophages are involved in the phagocytosis of wasteosomes, with CD206 and CD35 receptors playing a role in the process. The interaction between wasteosomes and macrophages can vary in physiological and altered conditions, affecting inflammatory responses.

CELL AND BIOSCIENCE (2022)

Article Cell Biology

From corpora amylacea to wasteosomes: History and perspectives

Marta Riba et al.

Summary: The article summarizes research findings on CA in human organs and proposes that CA may function as waste containers created by specific cells to sequester waste and foreign products in glycan structures, which are then secreted and phagocytosed. The proposal aims to explain the varied content of CA, the presence of fibrillary amyloid proteins in some but not all CA, and the intracellular or extracellular nature of CA structures. It also suggests renaming CA as "wasteosomes" to emphasize their role in trapping waste rather than their misleading amyloid properties.

AGEING RESEARCH REVIEWS (2021)

Article Clinical Neurology

Homozygous R136S mutation in PRNP gene causes inherited early onset prion disease

Teresa Ximelis et al.

Summary: This study reports a rare inherited early-onset prion disease caused by a rare PRNP homozygous mutation R136S, with neuropathological and molecular features consistent with Gerstmann-Straussler-Scheinker phenotype. The highly familial prion disease shows evidence for a potentially recessive pattern of inheritance.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Immunology

Corpora Amylacea in the Human Brain Exhibit Neoepitopes of a Carbohydrate Nature

Marta Riba et al.

Summary: Corpora amylacea (CA) in the human brain are polyglucosan bodies that accumulate residual substances originated from aging, neurodegenerative and infectious processes. Recent studies suggest that CA contain specific neoepitopes (NEs) that may be carbohydrate in nature. Experiments show that binding between certain natural IgMs and epitopes in CA could be disrupted by certain monosaccharides.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Tau: It's Not What You Think

Peter W. Baas et al.

TRENDS IN CELL BIOLOGY (2019)

Review Neurosciences

The neuropathological diagnosis of Alzheimer's disease

Michael A. DeTure et al.

MOLECULAR NEURODEGENERATION (2019)

Article Multidisciplinary Sciences

Corpora amylacea act as containers that remove waste products from the brain

Marta Riba et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains

Liang Qiang et al.

CURRENT BIOLOGY (2018)

Article Clinical Neurology

Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease

Andrew J. Aschenbrenner et al.

NEUROLOGY (2018)

Article Multidisciplinary Sciences

Exploring the elusive composition of corpora amylacea of human brain

Elisabet Auge et al.

SCIENTIFIC REPORTS (2018)

Article Immunology

Defining Natural Antibodies

Nichol E. Holodick et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

New perspectives on corpora amylacea in the human brain

Elisabet Auge et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Tau stabilizes microtubules by binding at the interface between tubulin heterodimers

Harindranath Kadavath et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Clinical Neurology

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Biochemical Research Methods

NIH Image to ImageJ: 25 years of image analysis

Caroline A. Schneider et al.

NATURE METHODS (2012)

Review Immunology

The importance of natural IgM: scavenger, protector and regulator

Michael R. Ehrenstein et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Review Biochemical Research Methods

State of the art in antigen retrieval for immunohistochemistry

Fabio D'Amico et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2009)

Article Biochemistry & Molecular Biology

Corpora amylacea from multiple sclerosis brain tissue consists of aggregated neuronal cells

Krzysztof Selmaj et al.

ACTA BIOCHIMICA POLONICA (2008)

Article Immunology

Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion

N Baumgarth et al.

SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)